Sensei Biotherapeutics
SNSE
SNSE
24 hedge funds and large institutions have $2.43M invested in Sensei Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$58.2K | |
| 2 | +$17K | |
| 3 | +$10.1K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$155 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$121 |
Top Sellers
| 1 | -$553K | |
| 2 | -$69K | |
| 3 | -$4.93K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.67K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.48K |